Published in Clin Chem on September 01, 2001
Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One (2011) 2.29
Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One (2011) 2.24
Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A (2005) 1.81
Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci U S A (2014) 1.68
Naturally acquired microchimerism. Int J Dev Biol (2010) 1.47
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br J Cancer (2011) 1.30
Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One (2013) 1.28
MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A (2004) 1.12
Fetal DNA detection in maternal plasma throughout gestation. Hum Genet (2005) 1.09
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Anal Bioanal Chem (2014) 1.08
Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One (2013) 1.08
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer (2010) 1.07
Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One (2011) 1.05
Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. J Mol Diagn (2015) 1.04
Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield. PLoS One (2011) 0.99
Epigenetic-genetic chromosome dosage approach for fetal trisomy 21 detection using an autosomal genetic reference marker. PLoS One (2010) 0.94
Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA. PLoS One (2012) 0.92
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol (2006) 0.92
Quantification of circulating DNA: in the preparation lies the rub. Clin Chem (2001) 0.90
Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin Chem (2003) 0.90
Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome. PLoS One (2010) 0.89
Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood. PLoS One (2009) 0.89
Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS One (2014) 0.85
The struggle to detect circulating DNA. Crit Care (2006) 0.85
Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC). PLoS One (2016) 0.85
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. Br J Cancer (2011) 0.84
Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues. PLoS One (2014) 0.83
Systematic identification of spontaneous preterm birth-associated RNA transcripts in maternal plasma. PLoS One (2012) 0.81
Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma. Transfus Med Hemother (2013) 0.81
Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. World J Gastroenterol (2006) 0.79
Evaluation of two DNA extraction methods from maternal plasma for using in non-invasive bovine fetus gender determination. Iran J Reprod Med (2012) 0.79
Evaluation of sample stability and automated DNA extraction for fetal sex determination using cell-free fetal DNA in maternal plasma. Biomed Res Int (2013) 0.77
Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies. BMC Pregnancy Childbirth (2002) 0.76
Circulating DNA demonstrates convergent evolution and common resistance mechanisms during treatment of colorectal cancer. Clin Cancer Res (2017) 0.76
A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection. PLoS One (2016) 0.75
Chimeric External Control to Quantify Cell Free DNA in Plasma Samples by Real Time PCR. Avicenna J Med Biotechnol (2016) 0.75
Size-selective separation and overall-amplification of cell-free fetal DNA fragments using PCR-based enrichment. Sci Rep (2017) 0.75
Epigenetic modifications at DMRs of placental genes are subjected to variations in normal gestation, pathological conditions and folate supplementation. Sci Rep (2017) 0.75
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer. Oncotarget (2016) 0.75
The Most Favourable Procedure for the Isolation of Cell-Free DNA from the Plasma of Iso-Immunized RHD-Negative Pregnant Women. J Circ Biomark (2015) 0.75
Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. Cancer Med (2017) 0.75
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet (1998) 6.88
Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill (2013) 4.37
Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet (1999) 3.39
Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill (2013) 2.99
Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med (2001) 2.27
Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem (1999) 2.26
False-positive results and the polymerase chain reaction. Lancet (1988) 2.22
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res (1999) 2.19
Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol (2015) 2.07
Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet (2000) 1.97
The quality of citations in major international obstetrics and gynecology journals. Am J Obstet Gynecol (1997) 1.94
Detection of single-copy fetal DNA sequence from maternal blood. Lancet (1990) 1.85
Temperature-sensitive copy number mutants of CoIE1 are located in an untranslated region of the plasmid genome. Proc Natl Acad Sci U S A (1982) 1.83
Clinical determinants of the outcome of manual stretching in the treatment of congenital muscular torticollis in infants. A prospective study of eight hundred and twenty-one cases. J Bone Joint Surg Am (2001) 1.82
Pyometra. What is its clinical significance? J Reprod Med (2001) 1.74
Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem (2001) 1.72
Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. Lancet (1993) 1.71
Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill (2014) 1.69
Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5' conserved sequences. J Virol (1998) 1.68
Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem (1999) 1.65
Rapid aneuploidy testing (knowing less) versus traditional karyotyping (knowing more) for advanced maternal age: what would be missed, who should decide? Hong Kong Med J (2008) 1.61
Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem (2000) 1.60
A hairpin loop at the 5' end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro. J Virol (1999) 1.58
How accurate are references in the Australian and New Zealand Journal of Surgery? Aust N Z J Surg (1997) 1.58
The clinical presentation and outcome of treatment of congenital muscular torticollis in infants--a study of 1,086 cases. J Pediatr Surg (2000) 1.58
Head-to-body delivery interval and risk of fetal acidosis and hypoxic ischaemic encephalopathy in shoulder dystocia: a retrospective review. BJOG (2010) 1.55
Comparison of perinatal outcomes of shoulder dystocia alleviated by different type and sequence of manoeuvres: a retrospective review. BJOG (2011) 1.53
Change in prevalence of group B Streptococcus maternal colonisation in Hong Kong. Hong Kong Med J (2009) 1.48
Presence of fetal RNA in maternal plasma. Clin Chem (2000) 1.45
Incidence of preterm delivery in Hong Kong Chinese. Aust N Z J Obstet Gynaecol (1998) 1.43
Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus? Acta Obstet Gynecol Scand (1998) 1.39
Intraoperative laparoscopic sonography for improved preoperative sonographic pathologic characterization of adnexal masses. J Ultrasound Med (1998) 1.38
Relationship between birthweight and repeated courses of antenatal corticosteroids. Aust N Z J Obstet Gynaecol (2001) 1.37
Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity. J Virol (2001) 1.35
Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol (2011) 1.35
Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem (1999) 1.35
Fetal intra-abdominal umbilical vein varix: what is the clinical significance? Ultrasound Obstet Gynecol (2005) 1.35
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet (2000) 1.34
Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet (1998) 1.33
Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn (2012) 1.25
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet (2005) 1.25
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res (2000) 1.22
Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat (2005) 1.21
Trends in maternal obesity and associated risks of adverse pregnancy outcomes in a population of Chinese women. BJOG (2008) 1.18
Maternal plasma fetal DNA as a marker for preterm labour. Lancet (1998) 1.16
A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model. Hum Reprod (2001) 1.16
Poor perinatal outcome associated with vasa previa: is it preventable? A report of three cases and review of the literature. Ultrasound Obstet Gynecol (1998) 1.16
A study on placental transfer of diclofenac in first trimester of human pregnancy. Hum Reprod (2000) 1.14
Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo. Mech Dev (1999) 1.13
A dose-response study of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg (2000) 1.13
Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Ultrasound Obstet Gynecol (2009) 1.13
Detection of Plasmodium falciparum DNA in plasma. Ann N Y Acad Sci (2001) 1.12
Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem (2001) 1.12
HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology (1994) 1.10
Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy. Br J Haematol (1998) 1.08
Alternative conformations of the ColE1 replication primer modulate its interaction with RNA I. Cell (1985) 1.07
Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol (2000) 1.06
Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet (1992) 1.06
Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong. J Clin Microbiol (2006) 1.04
Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin Chem (1999) 1.04
Intracardiac leiomyomatosis. Case report and literature review. Arch Gynecol Obstet (2001) 1.04
The impact of human copy number variation on a new era of genetic testing. BJOG (2010) 1.03
Fetal biometry in ethnic Chinese: biparietal diameter, head circumference, abdominal circumference and femur length. Ultrasound Obstet Gynecol (2008) 1.02
Comparison of metaraminol and ephedrine infusions for maintaining arterial pressure during spinal anesthesia for elective cesarean section. Anesthesiology (2001) 1.01
Intrapartum cesarean delivery after successful external cephalic version: a meta-analysis. Obstet Gynecol (2004) 1.01
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet (2004) 1.00
An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model. Hum Reprod (2003) 0.99
A new recommendation for maternal weight gain in Chinese women. J Am Diet Assoc (2000) 0.99
Dichotomization of continuous measurements using generalized additive modelling--application in predicting intrapartum caesarean delivery. Stat Med (1999) 0.98
ISUOG practice guidelines: performance of first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol (2013) 0.96
The Randomized Nitric Oxide Tocolysis Trial (RNOTT) for the treatment of preterm labor. Am J Obstet Gynecol (2004) 0.95
Randomised double-blinded comparison of phenylephrine vs ephedrine for maintaining blood pressure during spinal anaesthesia for non-elective Caesarean section*. Anaesthesia (2008) 0.95
Messenger RNAs that are not synthesized by RNA polymerase II can be 3' end cleaved and polyadenylated. EMBO Rep (2000) 0.94
Customizing fetal biometric charts. Ultrasound Obstet Gynecol (2003) 0.94
Longitudinal changes in trunkal balance after selective fusion of King II curves in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) (2000) 0.93
Antihypertensive pyrrolo[1,2-c]quinazolines and pyrrolo[1,2-c]quinazolinones. J Med Chem (1981) 0.93
Prenatal diagnosis of intra-abdominal mature testicular teratoma. J Ultrasound Med (2001) 0.92
Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med (1999) 0.91
High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia (1996) 0.91
A longitudinal observational study of preference for elective caesarean section among nulliparous Hong Kong Chinese women. BJOG (2007) 0.91